Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
ACS Appl Mater Interfaces ; 13(38): 45149-45160, 2021 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-34520182

RESUMO

The removal of uremic toxins from patients with acute kidney injury is a key issue in improving the quality of life for people requiring peritoneal dialysis. The currently utilized method for the removal of uremic toxins from the human organism is hemodialysis, performed on semipermeable membranes where the uremic toxins, along with small molecules, are separated from proteins and blood cells. In this study, we describe a mixed-linker modulated synthesis of zirconium-based metal-organic frameworks for efficient removal of uremic toxins. We determined that the efficient adsorption of uremic toxins is achieved by optimizing the ratio between -amino functionalization of the UiO-66 structure with 75% of -NH2 groups within organic linker structure. The maximum adsorption of hippuric acid and 3-indoloacetic acid was achieved by UiO-66-NH2 (75%) and by UiO-66-NH2 (75%) 12.5% HCl prepared by modulated synthesis. Furthermore, UiO-66-NH2 (75%) almost completely adsorbs 3-indoloacetic acid bound to bovine serum albumin, which was used as a model protein to which uremic toxins bind in the human body. The high adsorption capacity was confirmed in recyclability test, which showed almost 80% removal of 3-indoloacetic acid after the third adsorption cycle. Furthermore, in vitro cytotoxicity tests as well as hemolytic activity assay have proven that the UiO-66-based materials can be considered as potentially safe for hemodialytic purposes in living organisms.


Assuntos
Hipuratos/isolamento & purificação , Ácidos Indolacéticos/isolamento & purificação , Rins Artificiais , Estruturas Metalorgânicas/química , Ácidos Ftálicos/química , Toxinas Urêmicas/isolamento & purificação , Adsorção , Animais , Chlorocebus aethiops , Eritrócitos/efeitos dos fármacos , Células HEK293 , Hipuratos/química , Humanos , Ácidos Indolacéticos/química , Estruturas Metalorgânicas/síntese química , Estruturas Metalorgânicas/toxicidade , Ácidos Ftálicos/síntese química , Ácidos Ftálicos/toxicidade , Toxinas Urêmicas/química , Células Vero , Zircônio/química
2.
Toxins (Basel) ; 13(9)2021 09 04.
Artigo em Inglês | MEDLINE | ID: mdl-34564626

RESUMO

Removal of protein-bound uremic toxins (PBUTs) during conventional dialysis is insufficient. PBUTs are associated with comorbidities and mortality in dialysis patients. Albumin is the primary carrier for PBUTs and only a small free fraction of PBUTs are dialyzable. In the past, we proposed a novel method where a binding competitor is infused upstream of a dialyzer into an extracorporeal circuit. The competitor competes with PBUTs for their binding sites on albumin and increases the free PBUT fraction. Essentially, binding competitor-augmented hemodialysis is a reactive membrane separation technique and is a paradigm shift from conventional dialysis therapies. The proposed method has been tested in silico, ex vivo, and in vivo, and has proven to be very effective in all scenarios. In an ex vivo study and a proof-of-concept clinical study with 18 patients, ibuprofen was used as a binding competitor; however, chronic ibuprofen infusion may affect residual kidney function. Binding competition with free fatty acids significantly improved PBUT removal in pre-clinical rat models. Based on in silico analysis, tryptophan can also be used as a binding competitor; importantly, fatty acids or tryptophan may have salutary effects in HD patients. More chemoinformatics research, pre-clinical, and clinical studies are required to identify ideal binding competitors before routine clinical use.


Assuntos
Ligação Competitiva , Soluções para Diálise/química , Ibuprofeno/química , Diálise Renal , Toxinas Urêmicas/química , Humanos
3.
J Mol Recognit ; 34(10): e2901, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-33975380

RESUMO

The last 5 years have seen a series of advances in the application of isothermal titration microcalorimetry (ITC) and interpretation of ITC data. ITC has played an invaluable role in understanding multiprotein complex formation including proteolysis-targeting chimeras (PROTACS), and mitochondrial autophagy receptor Nix interaction with LC3 and GABARAP. It has also helped elucidate complex allosteric communication in protein complexes like trp RNA-binding attenuation protein (TRAP) complex. Advances in kinetics analysis have enabled the calculation of kinetic rate constants from pre-existing ITC data sets. Diverse strategies have also been developed to study enzyme kinetics and enzyme-inhibitor interactions. ITC has also been applied to study small molecule solvent and solute interactions involved in extraction, separation, and purification applications including liquid-liquid separation and extractive distillation. Diverse applications of ITC have been developed from the analysis of protein instability at different temperatures, determination of enzyme kinetics in suspensions of living cells to the adsorption of uremic toxins from aqueous streams.


Assuntos
Calorimetria/métodos , Descoberta de Drogas/métodos , Enzimas/química , Proteínas/química , Animais , Pesquisa Biomédica/métodos , Calorimetria/instrumentação , Catálise , Entropia , Enzimas/metabolismo , Humanos , Extração Líquido-Líquido/métodos , Minerais/química , Minerais/isolamento & purificação , Toxinas Urêmicas/química , Toxinas Urêmicas/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA